Healthcare & Life Sciences
Compass Therapeutics
United Statescompasstherapeutics.com
aliveseries-c-plus
series-c-plus
Stage
1
Investors
About
Compass Therapeutics develops oncology therapies by leveraging tumor microenvironment insights to create candidates that enhance anti-tumor immune responses, bridging innate and adaptive immunity.
Explore Compass Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.